IOL Chemicals & Pharmaceuticals' Q1 FY 2025-26 Quarterly Results

Result Summary

• IOL Chemicals & Pharmaceuticals Ltd reported a 9.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 9.7%.
• Its expenses for the quarter were up by 8.3% QoQ and 9.2% YoY.
• The net profit increased 22.8% QoQ and increased 13.2% YoY.
• The earnings per share (EPS) of IOL Chemicals & Pharmaceuticals Ltd stood at 1.2 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

IOL Chemicals & Pharmaceuticals Ltd is a company that operates primarily in the chemicals and pharmaceuticals industry. It is involved in the manufacturing and sale of organic chemicals and pharmaceutical active ingredients. As an integrated chemical and pharmaceutical manufacturer, the company supplies a wide range of products that include bulk drugs and intermediates. The company's operations are generally categorized into two segments: chemicals, which includes bulk drugs, and pharmaceuticals, which includes active pharmaceutical ingredients. At present, there is no additional information available regarding any recent major developments or changes in its operations.

Revenue

In the first quarter of fiscal year 2026 (Q1FY26), IOL Chemicals & Pharmaceuticals Ltd reported a total income of ₹559.06 crores, representing a 9.3% increase from the previous quarter (Q4FY25), where the total income was ₹511.44 crores. Compared to the same quarter in the previous fiscal year (Q1FY25), when total income was ₹509.76 crores, there was an increase of 9.7%. This indicates a steady growth in revenue over both the quarter and the year. This growth can be observed through consistent performance in revenue generation across the comparative periods provided.

Profitability

During Q1FY26, the profit before tax (PBT) was ₹45.51 crores, reflecting a 22.3% increase from the previous quarter's PBT of ₹37.20 crores. When compared to Q1FY25, where the PBT was ₹39.52 crores, the increase amounted to 15.2%. The profit after tax (PAT) for Q1FY26 was ₹33.93 crores, which is an increase of 22.8% from the previous quarter's PAT of ₹27.62 crores, and a 13.2% increase from Q1FY25's PAT of ₹29.97 crores. The taxation for the first quarter of FY26 was ₹11.58 crores, showing a 20.9% increase from Q4FY25 and a 21.3% increase from Q1FY25. The earnings per share (EPS) experienced a significant decline, with a value of ₹1.20 in Q1FY26 compared to ₹4.70 in Q4FY25 and ₹5.10 in Q1FY25, reflecting decreases of 74.5% and 76.5% quarter-over-quarter and year-over-year, respectively.

Operating Metrics

The total expenses for Q1FY26 were reported at ₹513.55 crores, which represents an 8.3% increase from the Q4FY25 expenses of ₹474.24 crores and a 9.2% increase from Q1FY25 expenses of ₹470.24 crores. This rise in expenses corresponds with the company's revenue growth, maintaining a correlation between income and expenditures. While the financial data does not provide specific breakdowns of expense categories or additional operating metrics such as financial ratios, the significant trends in both revenue and expenses indicate operational activity over the quarters. However, the notable reduction in EPS warrants attention, as it contrasts with the growth in profit metrics.